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Summary Gross cystic breast disease is a common condition. Women with apocrine breast cysts may be at
higher risk of breast cancer than women with cysts which are lined by flattened epithelium. Apocrine cysts
have been shown to be associated with higher intracystic levels of dehydroepiandrosterone sulphate and
intracystic sodium to potassium ratios of less than 3. In this study we measured the concentrations of
epidermal growth factor, dehydroepiandrosterone and'its sulphate in breast cyst fluid. The concentrations of
all three analytes were significantly higher in cysts with intracystic Na+/K+ ratios of less than 3 than in cysts
with electrolyte ratios of greater than or equal to 3 (P<0.001). The higher levels of EGF in cysts with low
intracystic electrolyte ratios may provide an explanation of why women with apocrine cysts may be at greater
risk of breast cancer. Positive correlations were obtained between concentrations of EGF and DHAS and
between EGF and DHA, compatible with the view that intracystic EGF levels may be androgen-modulated.
A positive correlation was also obtained between DHA and DHAS concentrations which supports the view
that DHA in cyst fluid may be derived from the metabolism of DHAS in the breast cyst wall.
Gross cystic breast disease (cysts more than 3mm in
diameter) is a common condition affecting about 7% of
women in the western world (Haagensen et al., 1981). Dixon
et al. (1983) have shown that these cysts can be divided into
two groups according to breast cyst fluid sodium to
potassium ratios, namely, Na+/K+ <3 (cysts lined by
apocrine epithelium) and Na /K+>3 (cysts lined by
flattened epithelium). Women with apocrine breast cysts may
be at a higher risk of subsequent development of breast
cancer than women with cysts which are lined by flattened
epithelium (Haagensen et al., 1981; Dixon et al., 1985).
Growth factors such as epidermal growth factor (EGF)
may be implicated in the development of human cancer
(Stoscheck & King, 1986). Wide-ranging concentrations of
EGF have been found in breast cyst fluid (Jaspar &
Franchimont, 1985). EGF has been shown to stimulate the
proliferation of mammary epithelial cells (Tonelli & Sorof,
1980) and human breast cancer cells in culture (Osborne et
al., 1980).
Dehydroepiandrosterone (DHA) and its sulphate (DHAS)
are also present in wide-ranging concentrations in breast cyst
fluid (Bradlow et al., 1983; Miller & Forrest, 1983). DHAS
is a marker of apocrine activity being present in high
concentrations in apocrine secretions (Labows et al., 1979).
Miller et al. (1986) found breast cyst fluid DHAS levels to
be significantly higher in apocrine cysts than in cysts lined
by flattened epithelium.
Since EGF production in some tissues is sensitive to sex
hormones, EGF levels in breast cyst fluid may be androgen-
modulated. This study was, therefore, designed to assess the
relationship between intracystic concentrations of EGF and
DHAS and between EGF and DHA.
Materials and methods
Patient samples
Needle aspiration of breast cysts was carried out as a
diagnostic procedure. The cyst fluid was centrifuged at
1,500g for 10min and the supernatant was stored at -20°C
until assayed. EGF was assayed on 105 cyst fluid samples.
DHAS and DHA were assayed on a smaller number of
samples (49 and 71 samples respectively), the remaining
samples being used in various other experiments. Cytological
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examination of cyst fluid was not performed. Approval for
this study was obtained from the local district ethics
committee.
Materials
Anti-human EGF antiserum, raised in Dutch male rabbits,
and pure urogastrone (EGF isolated from urine) were gifts
from Dr H. Gregory (ICI plc, Macclesfield, UK).
Recombinant human EGF, iodine-125 and 1,2,6,7-3H-DHA
(87Cimml-1) were obtained from Amersham International
plc (Amersham, Bucks, UK); 1,2,6,7,-3H-DHAS, ammonium
salt (92Cimmol-1), was purchased from DuPont (UK) Ltd
(NEN Products Division, Wedgewood Way, Stevenage,
Herts, UK). Anti-DHA antiserum was raised in rabbits
against DHA-7-carboxymethyloxime-bovine serum albumin.
Measurement of electrolytes
Sodium and potassium concentrations in cyst fluid were
measured by an indirect ion-selective electrode (Beckman
Electrolyte 2 Analyser).
Measurement of EGF
Tracer was prepared by iodination of recombinant human
EGF using chloramine T and purified on a Sephadex G-25
medium column.
The buffer used for the radioimmunoassay was 0.05 M
phosphate buffer, pH 7.4, containing 0.2% w/v bovine serum
albumin (RIA grade) and 0.1% w/v sodium azide. Assays
were performed in duplicate. Non-specific binding tubes and
total counts were included in each assay. Standards were
prepared from pure urogastrone in assay buffer.
An aliquot (0.1 ml) of standard (0, 0.05, 0.1, 0.2, 0.39,
0.78, 1.56, 3.12 and 6.25ngml-1) or sample was pre-
incubated with 0.1 ml of antiserum (working dilution of 1 in
30,000 with a zero binding of 30%) diluted in assay buffer
containing non-immune rabbit serum (4jlml-1) and 0.2ml
of assay buffer overnight at 4°C. An aliquot (0.1 ml) of
labelled antigen (about 8,000 c.p.m.) was then added and the
tubes were incubated overnight at 4°C for 2 days. Donkey
anti-rabbit immunoglobulin G (0.1 ml) was added and the
tubes incubated overnight at 4°C. The tubes were centrifuged
at 1,500g for 15min at 4°C and the pellets counted for 2min
each on a gamma counter.
The sensitivity of this assay was determined from the
precision of 10 pairs of zero standards (2 s.d. of the mean
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zero binding) and was 0.04ngml -1. The intra-assay
coefficient of variation (c.v.), calculated using the difference
between duplicates, was 8.6% (n=20 pairs). The inter-assay
c.v. was 7.4% at a concentration of 84.6ngml-1 (n=5).
Breast cyst fluid was assayed in several dilutions and the
competitive binding curves for the sample dilutions were
parallel to that of the standard curve.
Measurement of DHA and DHAS
The methodology for the measurement of DHA and DHAS
has been described by Jones and James (1987).
The sensitivity of the DHA assay was 2nmol1-1, the
intra-assay c.v., determined from 10 duplicates, was 12%
and the inter-assay c.v. for a concentration of 12.8nmoll-P
was 12.6% (n=5).
The sensitivity of the DHAS assay was 0.24 moll-1, the
intra-assay c.v., determined from 12 dupicates, was 4.1%
and the inter-assay c.v. for a concentration of 4.85pmoll-P
was 8.7% (n=6).
The mean recoveries (± 1 s.d.) after thin layer
chromatography were 79.4+7.9% (n=20) for the DHA assay
and 65.6+7.3% (n=27) for the DHAS assay.
Statistical analyses
The distributions of the various analytes were not Gaussian.
Non-parametric statistics were, therefore, used. Wilcoxon's
rank sum test was used to compare differences between the
distributions of the various analytes in the two groups of
breast cysts as defined by their sodium to potassium ratios.
Correlations were assessed using Spearman's rank
correlation method (Spearman's rank correlation
coefficient=r.). Results were regarded to be statistically
significant when P<0.05.
Results
The frequency polygon of log 10 Na+/K+ shows a bimodal
distribution (Figure 1). A cut-off point of Na+/K+=3,
which appeared to reasonably separate the two groups of
breast cysts, was arbitrarily chosen.
EGF concentrations in the low electrolyte ratio group,
i.e. Na+/K+<3 (median=319ngml-', n=66), were
significantly higher than the concentrations in the high electro-
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lyte ratio group, i.e. Na+/K+.>3 (median=71ngml-',
n=39), P<0.0003 (Figure 2).
Figure 3 shows the concentrations of DHAS in the two
cyst groups. DHAS levels in the low electrolyte ratio group
(median= 155Mmol -1, n= 31) were significantly higher than
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Figure 2 EGF concentrations in the two groups of breast cysts.
The horizontal lines represent median concentrations in each cyst
group: 319ngml-1 (n =66) in the low electrolyte ratio group and
71 ngml- I (n =39) in the high electrolyte ratio group. P<0.0003
between groups.
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Figure 1 Frequency polygon of log10 Na+/K+. The dotted line
represents the cut-off between the two groups of breast cysts.
Figure 3 DHAS concentrations in the two groups of breast
cysts. The horizontal lines represent median concentrations in
each cyst group: 155 moll-1 (n=31) in the low electrolyte ratio
group and 16pmolI1- (n = 18) in the high electrolyte ratio group.
P<0.001 between groups.
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in the high electrolyte ratio group (median= 16pmol j-1,
n=18), P<0.00l.
The concentrations of DHA in the low electrolyte ratio
group (median=22nmoll-1, n=45) were also significantly
higher than in the high electrolyte ratio group
(median= 10.7nmoll-1, n=26), P<0.001 (Figure 4).
Figure 5 shows EGF concentrations versus DHAS con-
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Figure 6 EGF concentration versus DHA concentration (n=71,
r =0.48, P<O.OO1).
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Figure 4 DHA concentrations in the two groups of breast cysts.
The horizontal lines represent median concentrations in each cyst
group: 22 nmolI1 (n=45) in the low electrolyte ratio group and
10.7 nmol 1- 1 (n =26) in the high electrolyte ratio group.
P<0.001 between groups.
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Figure 7 DHA concentration versus DHAS concentration
(n=48, r,=0.76, P<0.001).
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Figure 5 EGF concentration versus
(n=49, r,=0.81, P<0.001).
centrations. A positive correlation was obtained between the
two analytes (n=49, r,=0.81, P<0.001).
Figure 6 shows that a weaker positive correlation was
obtained between EGF and DHA concentrations (n
=71,
rs=0.48, P<0.001).
A positive correlation (n=48, r,=0.76, P<0.001) was
obtained between concentrations of DHA and DHAS in
breast cyst fluid (Figure 7).
Discussion
I . Testosterone has been shown to increase serum and
50 600 750 submaxillary salivary gland levels of EGF (Perheentupa et
11-1) al., 1984) and oestradiol to increase EGF-related polypeptide
production by various human cancer cell lines (Lippman et
DHAS concentration al., 1985). In addition, oestradiol has been shown to increase
uterine EGF concentrations in immature mice (Gonzalez et
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al., 1984). The positive correlations obtained in this study
between concentrations of EGF and DHAS and between
concentrations of EGF and DHA are compatible with the
view that concentrations of EGF in breast cyst fluid may be
androgen-modulated, although a common stimulus elevating
the levels of EGF, DHAS and DHA is also a possibility. An
alternative explanation for these positive correlations may be
that concentrations of EGF, DHAS and DHA in cyst fluid
are a reflection of secretory activity, higher concentrations
being present where cysts are lined by apocrine epithelium.
Levels of EGF in plasma are almost undetectable (Oka &
Orth, 1983), which makes the hypothesis that EGF may be
actively transported into cyst fluid from plasma, and that
this transport is enhanced by apocrine epithelium, less
attractive. No evidence has been obtained thus far to
support the hypothesis that EGF concentrations in breast
cyst fluid may be modulated by oestrogens. Preliminary
experiments have failed to reveal any correlation between
EGF and total or unbound oestradiol concentrations
(n =25).
Bradlow et al. (1983) showed that, following intravenous
administration of radiolabelled hormones to patients with
breast cysts, only labelled DHAS accumulated in significant
amounts in breast cyst fluid. No significant accumulation of
labelled steroids occurred in breast cyst fluid after
administration of labelled cortisol, testosterone, dihydro-
testosterone, DHA, androsterone, oestradiol, oestrone
sulphate or oestradiol-3-sulphate. In addition, they
demonstrated the failure of 3H20 or 14C-antipyrine to enter
breast cyst fluid readily, indicating the presence of tight
junctions between the epithelial cells lining the cyst wall. As
DHAS concentrations are higher in breast cyst fluid than in
plasma (Angeli et al., 1982), this steroid is likely to be
actively transported into breast cyst fluid, and all of the
other steroids present in cyst fluid may be synthesised from
DHAS in situ. The positive correlation obtained between
DHA and DHAS concentrations in breast cyst fluid is
compatible with this hypothesis. Breast cyst wall is certainly
capable of metabolising labelled DHAS to other labelled
steroid metabolites in vitro (unpublished observation).
To the best of our knowledge the positive correlations
between EGF and DHA concentrations and between DHA
and DHAS concentrations have not been reported before.
The positive correlation between EGF and DHAS con-
centrations in breast cyst fluid, which we have published
previously in abstract form (Lai et al., 1988), is in agreement
with the findings of Boccardo et al. (1988).
In conclusion, the findings of this study are compatible
with the view that EGF concentrations in breast cyst fluid
may be androgen-modulated. In addition, the positive
correlation between DHA and DHAS concentrations in
breast cyst fluid supports the hypothesis that DHA is
derived from the metabolism of DHAS in situ. The higher
intracystic levels of EGF in cysts characterised by low
intracystic electrolyte ratios (<3) may provide an
explanation why women with apocrine cysts may be at
higher risk of breast cancer than women with cysts which are
lined by flattened epithelium if there is a strict relationship
between Na+/K+ ratio and cyst morphology as was shown
by Dixon et al. (1983).
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